KZR-616 Uses, Dosage, Side Effects and more
KZR-616 is under investigation in clinical trial NCT04033926 (A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis).
Trade Name | KZR-616 |
Generic | KZR-616 |
Type | |
Formula | C30H42N4O8 |
Weight | Average: 586.686 Monoisotopic: 586.300264328 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |